Initial Management of Suspected Sepsis
For suspected sepsis, immediately assess risk using NEWS2 score, obtain blood cultures if feasible without delay, administer IV antibiotics within 1 hour (high-risk patients) to 3 hours (moderate-risk), and aggressively resuscitate with at least 30 mL/kg IV crystalloid fluids within the first 3 hours. 1, 2
Risk Stratification and Monitoring
- Calculate NEWS2 score immediately to determine risk level: score ≥7 indicates high risk, 5-6 indicates moderate risk, and 0-4 indicates low risk of severe illness or death from sepsis 3, 1, 2
- Monitor high-risk patients every 30 minutes, moderate-risk patients every hour, and low-risk patients every 4-6 hours 2
- Obtain serum lactate measurement immediately; if elevated, remeasure within 2-4 hours to guide resuscitation 1
- Look for signs of tissue hypoperfusion including mottled skin, decreased capillary refill, peripheral cyanosis, altered mental status, and arterial hypotension 3, 1
Fluid Resuscitation
- Administer at least 30 mL/kg of IV crystalloid fluid within the first 3 hours for patients with sepsis-induced hypoperfusion or tissue hypoperfusion 3, 1, 2
- Use crystalloids (either balanced crystalloids or saline) as the initial fluid of choice 3, 1
- Continue aggressive fluid administration for 24-48 hours; more than 4 L during the first 24 hours may be required in adults 3
- Guide additional fluids after initial resuscitation by frequent reassessment of hemodynamic status using dynamic variables (pulse pressure variation, stroke volume variation) when available 3, 1
- Consider albumin in addition to crystalloids when patients require substantial amounts of crystalloids 3, 1
Antimicrobial Therapy Timing
The timing of antibiotics is risk-stratified:
- High-risk patients (NEWS2 ≥7): Administer IV antimicrobials within 1 hour of sepsis recognition 1, 2, 4
- Moderate-risk patients (NEWS2 5-6): Administer within 3 hours 2
- Low-risk patients (NEWS2 0-4): Administer within 6 hours 2
This stratified approach balances the need for rapid treatment in critically ill patients against antimicrobial stewardship concerns in lower-risk patients 3.
Culture Acquisition
- Obtain at least two sets of blood cultures (aerobic and anaerobic) before initiating antimicrobials if this can be done without substantial delay (suggested maximum 45 minutes) 3, 1, 4
- All blood cultures may be drawn together on the same occasion; sequential draws or timing to temperature spikes does not improve yield 3
- For patients with intravascular catheters in place >48 hours, obtain at least one blood culture set from the catheter along with simultaneous peripheral blood cultures 3
- Obtain cultures from other sites (urine, wounds, respiratory secretions, cerebrospinal fluid) only when clinically indicated as potential sources; avoid "pan-culturing" all possible sites 3
- Do not delay antibiotics beyond 1 hour in high-risk patients to obtain cultures—the mortality risk of delaying antibiotics outweighs the benefit of pre-antibiotic cultures 3, 1
Antibiotic Selection
- Use empiric broad-spectrum therapy with one or more antimicrobials to cover all likely pathogens (bacterial, and potentially fungal or viral) 1, 4
- For septic shock specifically, use empiric combination therapy with at least two antibiotics from different antimicrobial classes aimed at the most likely bacterial pathogens 1, 4
- Consider local resistance patterns and whether infection was healthcare-acquired, as these patients have higher risk of resistant pathogens 2
- Optimize dosing strategies based on pharmacokinetic/pharmacodynamic principles and specific drug properties 1, 4
Hemodynamic Support
- Target mean arterial pressure (MAP) of 65 mmHg in patients requiring vasopressors 1, 2
- Initiate vasopressor therapy when fluid resuscitation fails to restore adequate MAP and organ perfusion 5
- Perform further hemodynamic assessment (such as cardiac function evaluation) if clinical examination doesn't lead to a clear diagnosis 1, 2
Source Control
- Identify or exclude anatomic diagnosis of infection requiring source control as rapidly as possible, and implement required intervention as soon as medically and logistically practical 3
- Remove intravascular access devices that are potential sources of sepsis promptly after establishing other vascular access 3, 1
- When feasible, perform source control intervention within the first 12 hours after diagnosis 3, 2
De-escalation and Duration
- Review antimicrobial regimen daily for possible de-escalation once culture results are available 3, 1, 4
- Narrow empiric antimicrobial therapy once pathogen identification and sensitivities are established and/or adequate clinical improvement is noted 1, 4
- Discontinue empiric combination therapy within 3-5 days in response to clinical improvement 1, 4
- Typical treatment duration is 7-10 days; longer courses may be necessary for slow clinical response, undrainable infection sites, or specific pathogens 1, 4
- Consider using procalcitonin levels to support discontinuation of empiric antibiotics in patients who initially appeared septic but have limited clinical evidence of infection 3, 1
Critical Pitfalls to Avoid
- Do not delay antibiotics in high-risk patients (NEWS2 ≥7) beyond 1 hour while waiting for cultures or additional testing—mortality increases significantly with delays 3, 1, 6
- Do not use hydroxyethyl starches for fluid resuscitation, as they are associated with harm 3, 1
- Avoid inadequate initial fluid resuscitation—be aggressive with the initial 30 mL/kg bolus, as under-resuscitation is associated with increased mortality 3, 1
- Do not continue broad-spectrum combination therapy beyond 3-5 days without reassessment—practice antimicrobial stewardship 1, 4
- Interpret NEWS2 scores in the context of the patient's underlying physiology and comorbidities, as baseline abnormalities may affect accuracy 3, 1